Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Prepaid Assets: 2015-2024

Historic Prepaid Assets for Cartesian Therapeutics (RNAC) over the last 10 years, with Dec 2024 value amounting to $3.1 million.

  • Cartesian Therapeutics' Prepaid Assets fell 23.61% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 23.61%. This contributed to the annual value of $3.1 million for FY2024, which is 36.70% down from last year.
  • Cartesian Therapeutics' Prepaid Assets amounted to $3.1 million in FY2024, which was down 36.70% from $5.0 million recorded in FY2023.
  • Over the past 5 years, Cartesian Therapeutics' Prepaid Assets peaked at $6.5 million during FY2021, and registered a low of $3.1 million during FY2024.
  • In the last 3 years, Cartesian Therapeutics' Prepaid Assets had a median value of $3.8 million in 2022 and averaged $4.0 million.
  • In the last 5 years, Cartesian Therapeutics' Prepaid Assets skyrocketed by 263.48% in 2020 and then crashed by 41.64% in 2022.
  • Cartesian Therapeutics' Prepaid Assets (Yearly) stood at $5.4 million in 2020, then rose by 19.14% to $6.5 million in 2021, then crashed by 41.64% to $3.8 million in 2022, then surged by 31.47% to $5.0 million in 2023, then slumped by 36.70% to $3.1 million in 2024.